VivaMed

VivaMed is a medical device company, part of the InCube Labs portfolio, focused on developing a minimally invasive, catheter-based neuromodulation therapy for the treatment of heart failure. The company's proprietary VivaMed System targets the carotid sinus to modulate the autonomic nervous system, aiming to restore balance and improve cardiac function in patients with heart failure with reduced ejection fraction (HFrEF). By utilizing a catheter-based approach, VivaMed seeks to provide a less invasive alternative to traditional surgical baroreflex activation therapies. The technology is designed to reduce the overactivity of the sympathetic nervous system, which is a hallmark of heart failure progression.